APP and Alzheimer disease: In addition to our own findings, our colleagues have shown that the APP 5′-UTR-directed drugs posiphen and phenserine inhibit APP translation to generate anti-amyloid efficacies [78,79] for the purpose of treating AD as effectively as current anti-inflammatory pathways [80].